The efficacy of landiolol for suppressing the hyperdynamic response following laryngoscopy and tracheal intubation: A systematic review

Anaesthesia and Intensive Care

Volumn 37, Issue 6, 2009, Pages 893-902

  Inoue, S ^a   Tanaka, Y ^a   Kawaguchi, M ^a   Furuya, H ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Haemodynamic response; Landiolol; Laryngoscopy; Tracheal intubation

Indexed keywords

LANDIOLOL; PLACEBO;

BRADYCARDIA; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; ENDOTRACHEAL INTUBATION; FOLLOW UP; HEART RATE; HEMODYNAMICS; HUMAN; HYPOTENSION; LARYNGOSCOPY; MEAN ARTERIAL PRESSURE; MEDICAL SOCIETY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 74049087495     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0903700621     Document Type: Review

References (35)

1. Dahlgren N, Messeter K. Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia 1981; 36:1022-1026.
2. Ebert JP, Pearson JD, Gelman S, Harris C, Bradley EL. Circulatory responses to laryngoscopy: the comparative effects of placebo, fentanyl and esmolol. Can J Anaesth 1989; 36:301-306.
3. Stone DJ, Gal TJ. Airway management. In: Miller RD ed. Anesthesia, 5th ed. New York: Churchill Livingstone Inc. 2000. p. 1444-1446.
4. Turner DA, Shribman AJ, Smith G, Achola KJ. Effect of halothane on cardiovascular and plasma catecholamine responses to tracheal intubation. Br J Anaesth 1986; 58:1365-1370.
5. Stoelting RK. Circulatory changes during direct laryngoscopy and tracheal intubation: influence of duration of laryngoscopy with or without prior lidocaine. Anesthesiology 1977; 47:381-384.
6. Angelard B, Debry C, Planquart X, Dubos S, Dominici L, Gondret R et al. [Difficult intubations. A prospective study]. Ann Otolaryngol Chir Cervicofac 1991; 108:241-243.
7. Bucx MJ, van Geel RT, Scheck PA, Stijnen T. Cardiovascular effects of forces applied during laryngoscopy. The importance of tracheal intubation. Anaesthesia 1992; 47:1029-1033.
8. Vohra A, Kumar S, Charlton AJ, Olukoga AO, Boulton AJ, McLeod D. Effect of diabetes mellitus on the cardiovascular responses to induction of anaesthesia and tracheal intubation. Br J Anaesth 1993; 71:258-261.
9. Low JM, Harvey JT, Prys-Roberts C, Dagnino J. Studies of anaesthesia in relation to hypertension. VII: Adrenergic responses to laryngoscopy. Br J Anaesth 1986; 58:471-477.
10. Figueredo E, Garcia-Fuentes EM. Assessment of the efficacy of esmolol on the haemodynamic changes induced by laryngoscopy and tracheal intubation: a meta-analysis. Acta Anaesthesiol Scand 2001; 45:1011-1022.
11. London MJ, Zaugg M, Schaub MC, Spahn DR. Perioperative beta-adrenergic receptor blockade: physiologic foundations and clinical controversies. Anesthesiology 2004; 100:170-175.
12. Tan P-H, Yang LC, Shih HC, Lin CR, Lan KC, Chen CS. Combined use of esmolol and nicardipine to blunt the haemodynamic changes following laryngoscopy and tracheal intubation. Anaesthesia 2002; 57:1207-1212.
13. Menigaux C, Guignard B, Adam F, Sessler DI, Joly V, Chauvin M. Esmolol prevents movement and attenuates the BIS response to orotracheal intubation. Br J Anaesth 2002; 89:857-862.
14. Deegan R, Wood AJ. Beta-receptor antagonism does not fully explain esmolol-induced hypotension. Clin Pharmacol Ther 1994; 56:223-228.
15. Yamazaki A, Kinoshita H, Shimogai M, Fujii K, Nakahata K, Hironaka Y et al. Landiolol attenuates tachycardia in response to endotracheal intubation without affecting blood pressure. Can J Anaesth 2005; 52:254-257.
16. Muraki K, Nakagawa H, Nagano N, Henmi S, Kawasumi H, Nakanishi T et al. Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle. J Pharmacol Exp Ther 1996; 278:555-563.
17. Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth 2001; 48:985-989.
18. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354:1896-1900.
19. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:1-12.
20. Hasuo H, Tomiyasu S, Hojo M, Fujigaki T, Fukusaki M, Sumikawa K. Effect of ONO-1101, a novel short-acting ß-blocker on hemodynamic responses to isoflurane inhalation and tracheal intubation. J Anesth 1998; 12:115-118.
21. Kawaguchi M, Takamatsu I, Masui K, Kazama T. Effect of landiolol on bispectral index and spectral entropy responses to tracheal intubation during propofol anaesthesia. Br J Anaesth 2008; 101:273-278.
22. Onaka M, Yamamoto H. [Effects of continuous infusion of landiolol on the hemodynamic response to tracheal intubation]. Masui 2006; 55:174-178.
23. G oyagi T, Tanaka M, Nishikawa T. Landiolol attenuates the cardiovascular response to tracheal intubation. J Anesth 2005; 19:282-286.
24. Kawano T, Eguchi S, Iseki A, Oshita S. [Effects of landiolol on cardiovascular responses, bispectral index and body movement during endotracheal intubation]. Masui 2005; 54:610-614.
25. O da Yutaka, Nishikawa Kiyonobu, Hase Ichiro, Asada Akira. The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia. Anesth Analg 2005; 100:733-737.
26. Kitamura A, Sakamoto A, Inoue T, Ogawa R. Efficacy of an ultrashort-acting beta-adrenoceptor blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation. Eur J Clin Pharmacol 1997; 51:467-471.
27. Miyazaki M, Kadoi Y, Takashi S, Sawano Y, Shimada H. Comparative effects of propofol, landiolol, and nicardipine on hemodynamic and bispectral index responses to endotracheal intubation: a prospective, randomized, double-blinded study. J Clin Anesth 2008; 20:257-262.
28. Hasuo H, Fukusaki M, Fujigaki T, Sumikawa K. Attenuation of the hemodynamic responses to endotracheal intubation with a new ultra short-acting β1-blocker, landiolol hydrochloride (ONO-1101). Rinsho Iyaku 1997; 13:4993-5008.
29. Hasuo H, Fukusaki M, Fujigaki T, Sumikawa K. Attenuation of the hemodynamic responses to endotracheal intubation with a new ultra short-acting β1-blocker, landiolol hydrochloride (ONO-1101). Rinsho Iyaku 2000; 16:1579-1593.
30. Sugiura S, Seki S, Hidaka K, Masuoka M, Tsuchida H. The hemodynamic effects of landiolol, an ultra-short-acting beta1-selective blocker, on endotracheal intubation in patients with and without hypertension. Anesth Analg 2007; 104:124-129.
31. Atarashi H, Kuruma A, Yashima M, Saitoh H, Ino T, Endoh Y et al. Pharmacokinetics of landiolol hydrochloride, a new ultrashort-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther 2000; 68:143-150.
32. Sugiyama A, Takahara A, Hashimoto K. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultrashort-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol 1999; 34:70-77.
33. Motomura S, Hagihara A, Narumi Y, Hashimoto K. Time course of a new ultrashort-acting beta-adrenoceptor-blocking drug, ONO-1101: comparison with those of esmolol and propranolol by using the canine isolated, blood-perfused heart preparations. J Cardiovasc Pharmacol 1998; 31:431-440.
34. Yoshiya I, Ogawa R, Okumura F, Shimada Y, Hanaoka K. Clinical evaluation of landiolol hydrochloride (ONO-1101) on perioperative supraventricular tachycardia-A phase III, double-blind study in comparisom with placebo [Japanese]. Rinsho Iyaku 1997; 13:4949-4978.
35. Ikeshita K, Nishikawa K, Toriyama S, Yamashita T, Tani Yi, Yamada T et al. Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts. J Anesth 2008; 22:361-366.